Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients

European Journal of Clinical Pharmacology

Volumn 67, Issue 12, 2011, Pages 1243-1252

  Barraclough, Katherine A ^a   Isbel, Nicole M ^a   McWhinney, Brett C ^b   Ungerer, Jacobus P J ^b   Medley, Gregory ^c   Johnson, David W ^a   Hawley, Carmel M ^a   Leary, Diana R ^a   Campbell, Scott B ^a   Staatz, Christine E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Area under the concentration time curve; Limited sampling strategies; Prednisolone; Therapeutic drug monitoring

Indexed keywords

ALBUMIN; CREATININE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACCURACY; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG MONITORING; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMATOCRIT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIMITED SAMPLING STRATEGY; MALE; MAXIMUM PLASMA CONCENTRATION; MEASUREMENT ERROR; PHARMACOLOGICAL PARAMETERS; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; AREA UNDER CURVE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

EID: 82455188040     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1071-y     Document Type: Article

References (29)

1. Brent L (1997) History of transplantation immunology. Academic Press, San Diego
2. U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. http://www.ustransplant.org/annual-reports/ current/. Accessed August 18, 2009
3. JM Morton S Williamson LM Kear BC McWhinney J Potter AR Glanville 2006 Therapeutic drug monitoring of prednisolone after lung transplantation J Heart Lung Transplant 25 5 557 563 16678035 10.1016/j.healun.2005.11.460
4. JM Potter BC McWhinney L Sampson PE Hickman 2004 Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population Ther Drug Monit 26 4 408 414 15257071 10.1097/00007691-200408000- 00011 1:CAS:528:DC%2BD2cXls1Kjtbg%3D (Pubitemid 38989660)
5. HA Bergrem H Bergrem A Hartmann T Jenssen 2008 Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation Ther Drug Monit 30 5 583 590 18728625 10.1097/FTD.0b013e318187bb2f 1:CAS:528: DC%2BD1cXht1aisLzL
6. H Bergrem J Jervell A Flatmark 1985 Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients Kidney Int. 27 2 459 464 3887001 10.1038/ki.1985.31 1:STN:280:DyaL2M7os1alug%3D%3D (Pubitemid 15142701)
7. JG Gambertoglio F Vincenti NJ Feduska J Birnbaum O Salvatierra Jr WJ Amend Jr 1980 Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients J Clin Endocrinol Metab 51 3 561 565 6997330 10.1210/jcem-51-3-561 1:STN:280:DyaL3M%2FgslajsQ%3D%3D (Pubitemid 10022841)
8. M Kozower L Veatch MM Kaplan 1974 Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects J Clin Endocrinol Metab 38 3 407 412 4815171 10.1210/jcem-38-3-407 1:STN:280:DyaE2c7htFenug%3D%3D
9. P Wallemacq VW Armstrong M Brunet V Haufroid DW Holt A Johnston, et al. 2009 Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference Ther Drug Monit 31 2 139 152 19177031 10.1097/FTD.0b013e318198d092 1:CAS:528:DC%2BD1MXjsFWqsb0%3D
10. BC McWhinney SE Briscoe JP Ungerer CJ Pretorius 2010 Measurement of cortisol, cortisone, prednisolone, dexamethasone and 11-deoxycortisol with ultra high performance liquid chromatography-tandem mass spectrometry: application for plasma, plasma ultrafiltrate, urine and saliva in a routine laboratory J Chromatogr B Analyt Technol Biomed Life Sci 878 28 2863 2869 20851063 10.1016/j.jchromb.2010.08.044 1:CAS:528:DC%2BC3cXht1CgsbvE
11. B Efron 1983 A leisurely look at the bootstrap, the jackknife, and cross-validation Am Stat 37 36 48 10.2307/2685844
12. LB Sheiner SL Beal 1981 Some suggestions for measuring predictive performance J Pharmacokinet Biopharm 9 4 503 512 7310648 10.1007/BF01060893 1:STN:280:DyaL38%2FnslGruw%3D%3D
13. LS Ting E Villeneuve MH Ensom 2006 Beyond cyclosporine: a systematic review of limited sampling strategies for other immunosuppressants Ther Drug Monit 28 3 419 430 16778729 10.1097/01.ftd.0000211810.19935.44 1:CAS:528:DC%2BD28Xls1KhtLc%3D (Pubitemid 44314932)
14. J Coresh LA Stevens 2006 Kidney function estimating equations: where do we stand? Curr Opin Nephrol Hypertens 15 3 276 284 16609295 10.1097/01.mnh. 0000222695.84464.61
15. http://www.R-project.org, R: a language and environment for statistical computing, R Development Core Team, R Foundation for Statistical Computing, Vienna, Austria, 2010
16. G Suarez-Kurtz C Estrela Rde MC Salvadori 2004 Prednisolone: limited sampling strategies for estimating pharmacokinetic parameters Ther Drug Monit 26 1 16 22 14749544 10.1097/00007691-200402000-00005 1:CAS:528: DC%2BD2cXkt1ymtg%3D%3D (Pubitemid 38140905)
17. L Ost I Bjorkhem C von Bahr 1984 Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation Eur J Clin Pharmacol 26 3 363 369 6376143 10.1007/BF00548768 1:STN:280:DyaL2c3js1elsg%3D%3D (Pubitemid 14139494)
18. WJ Jusko JQ Rose 1980 Monitoring prednisone and prednisolone Ther Drug Monit 2 2 169 176 6762710 10.1097/00007691-198004000-00011 1:CAS:528: DyaL3cXmtFGlsb8%3D (Pubitemid 10039571)
19. BM Frey FJ Frey 1990 Clinical pharmacokinetics of prednisone and prednisolone Clin Pharmacokinet 19 2 126 146 2199128 10.2165/00003088-199019020- 00003 1:STN:280:DyaK3czjs1amtw%3D%3D (Pubitemid 20211324)
20. JQ Rose AM Yurchak WJ Jusko 1981 Dose dependent pharmacokinetics of prednisone and prednisolone in man J Pharmacokinet Biopharm 9 4 389 417 7310640 10.1007/BF01060885 1:CAS:528:DyaL38XivV2htQ%3D%3D (Pubitemid 12252417)
21. HC Ko RR Almon WJ Jusko 1995 Effect of corticosteroid binding globulin on the pharmacokinetics of prednisolone in rats Pharm Res 12 6 902 904 7667198 10.1023/A:1016225423795 1:CAS:528:DyaK2MXmtFSjsrw%3D
22. H Bergrem 1983 Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis Kidney Int 23 6 876 881 6887699 10.1038/ki.1983.110 1:STN:280:DyaL3s3psFeruw%3D%3D (Pubitemid 13067058)
23. PL Ballard 1979 Delivery and transport of glucocorticoids to target cells Monogr Endocrinol 12 25 48 386085 1:CAS:528:DyaE1MXlvFSitb8%3D
24. FJ Frey MK Ruegsegger BM Frey 1986 The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone Br J Clin Pharmacol 21 2 183 189 3954934 1:CAS:528:DyaL28Xhs1aitLc%3D (Pubitemid 17189978)
25. H Bergrem 2003 The influence of uremia on pharmacokinetics and protein binding of prednisolone Acta Med Scand 213 5 333 337 10.1111/j.0954-6820.1983. tb03747.x
26. E Renner FF Horber G Jost BM Frey FJ Frey 1986 Effect of liver function on the metabolism of prednisone and prednisolone in humans Gastroenterology 90 4 819 828 3512355 1:STN:280:DyaL287jslaluw%3D%3D (Pubitemid 16124757)
27. AE Stuck BM Frey FJ Frey 1988 Kinetics of prednisolone and endogenous cortisol suppression in the elderly Clin Pharmacol Ther 43 4 354 361 3356080 10.1038/clpt.1988.43 1:CAS:528:DyaL1cXhvFymur4%3D
28. MH Magee RA Blum CD Lates WJ Jusko 2001 Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race J Clin Pharmacol 41 11 1180 1194 11697751 10.1177/00912700122012733 1:CAS:528:DC%2BD3MXotlCktbg%3D (Pubitemid 32983217)
29. PQ Meffin PM Brooks BC Sallustio 1984 Alterations in prednisolone disposition as a result of time administration, gender and dose Br J Clin Pharmacol 20 4 395 404 (Pubitemid 14055268)